Shopping Cart 0
Cart Subtotal
USD 0

North America HLA Typing Transplant Diagnostics Services Market_, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 2500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 3200
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

North America HLA typing transplant diagnostics services is expected to register a healthy CAGR in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

The major factors contributing to the growth of the market includes factors such as technological advancements in HLA typing, increasing number of solid organ and stem cell transplantation procedures and increased research grants, funds, and public-private investments.

The key market players for North America HLA typing transplant diagnostics services are listed below:

Thermo Fisher Scientific Inc.

Proimmune ltd.

Laboratory Corporation Of America Holdings

Creative Biolabs and

Histogenetics LLC

THE UCLA immunogenetics center.

Admera Health

Quick Biology

NEW YORK blood center

The Sequencing Center

Bloodcenter of Wisconsin

Thermo Fisher Scientific Inc.

The market is further segmented into:

Technology

Technique

End-Users

The North America HLA typing transplant diagnostics services market is segmented on the basis of technology into polymerase chain reaction (PCR) and next-generation sequencing (NGS). In 2018, Polymerase Chain Reaction (PCR) is expected to dominate the hospital LIMS market with 52.0% market share growing at a CAGR of 8.6% in the forecast period 2018 to 2025. However, next-generation sequencing (NGS) segment is expected to grow at the highest CAGR in the forecast period.

The North America HLA typing transplant diagnostics services market is segmented on the basis of technique into PCR-SSP (Sequence-Specific Primer), PCR SSOP (Sequence-Specific Oligonucleotide) and PCR-SBT (Sequencing Based Typing). In 2018, PCR-SSP (Sequence-Specific Primer) is expected to dominate the market with highest market share and is growing at a healthy CAGR in the forecast period 2018 to 2025. However, PCR-SBT (Sequencing Based Typing) market segment is expected to grow at the highest CAGR in the forecast period.

The North America HLA typing transplant diagnostics services market is segmented on the basis of end-users into hospitals, transplant centers, specialty clinics and academic institutes. In 2018, on-premise hospital LIMS is expected to dominate the hospital LIMS market in the forecast period 2018 to 2025. However, hospitals market segment is expected to grow at the highest CAGR and is expected to reach USD 185.24 million in 2025.

Based on geography, the market is segmented into 3 geographical regions:

U.S.

Canada

Mexico

Covered in this report

The report covers the present scenario and the growth prospects of the North America HLA typing transplant diagnostics services for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.

READ MORE

Table Of Content

Scope

Table Of Contents

1. Introduction 14

1.1. Objectives Of The Study 14

1.2. Market Definition 14

1.3. Overview Of North America Hla Typing Transplant Diagnostics Services Market 14

1.4. Currency And Pricing 15

1.5. Limitation 15

1.6. Markets Covered 16

2. Market Segmentation 18

2.1. Markets Covered 18

2.2. Geographic Scope 19

2.3. Years Considered For The Study 20

2.4. Currency And Pricing 20

2.5. Research Methodology 21

2.6. Primary Interviews With Key Opinion Leaders 24

2.7. Secondary Sources 25

2.8. Assumptions 25

3. Market Overview 26

3.1. Drivers 28

3.1.1. Technological Advancements In Hla Typing 28

3.1.2. Increasing Number Of Solid Organ And Stem Cell Transplantation Procedures 29

3.1.3. Increased Research Grants, Funds, And Public-Private Investments 29

3.2. Restraints 30

3.2.1. Weak Reimbursements For Organ Donation And Transplantation Procedures 30

3.2.2. Expensive Ngs And Pcr-Based Devices 30

3.3. Opportunities 31

3.3.1. Rising Healthcare Infrastructure In Emerging Nations 31

3.4. Challenges 32

3.4.1. Significant Gap Between Number Of Organs Donated And Organs Required Annually 32

3.4.2. Lack Of Trained Staff 33

4. Executive Summary 34

5. Premium Insights 36

6. North America Hla Typing Transplant Diagnostics Services Market, By Technology 39

6.1. Overview 40

6.2. Next-Generation Sequencing (Ngs) 42

6.3. Polymerase Chain Reaction (Pcr) 43

6.3.1. Pcr Ssop (Sequence-Specific Oligonucleotide) 44

6.3.2. Pcr Ssp (Sequence-Specific Primer) 44

6.3.3. Pcr-Sbt (Sequencing Based Typing) 45

7. North America Hla Typing Transplant Diagnostics Services Market, By End-User 46

7.1. Overview 47

7.2. Specialty Clinics 49

7.3. Hospitals 50

7.4. Transplant Centers 51

7.5. Academic Institutes 52

8. North America Hla Typing Transplant Diagnostics Services Market, By Geography 53

8.1. North America 53

8.1.1. U.S. 61

8.1.2. Canada 63

8.1.3. Mexico 65

9. North America Hla Typing Transplant Diagnostics Services Market, Company Landscape 67

9.1. Company Share Analysis: North America 67

10. Company Profiles 68

10.1. Proimmune Ltd. 68

10.1.1. Company Overview 68

10.1.2. Proimmune Ltd.: Company Snapshot 68

10.1.3. Product Portfolio 69

10.1.4. Recent Developments 69

10.2. Creative Biolabs 70

10.2.1. Company Overview 70

10.2.2. Creative Biolabs: Company Snapshot 70

10.2.3. Product Portfolio 70

10.2.4. Recent Developments 70

10.3. Histogenetics Llc 71

10.3.1. Company Overview 71

10.3.2. Histogenetics Llc: Company Snapshot 71

10.3.3. Product Portfolio 71

10.3.4. Recent Developments 71

10.4. The Ucla Immunogenetics Center 72

10.4.1. Company Overview 72

10.4.2. The Ucla Immunogenetics Center: Company Snapshot 72

10.4.3. Product Portfolio 72

10.4.4. Recent Developments 72

10.5. Admera Health 73

10.5.1. Company Overview 73

10.5.2. Admera Health: Company Snapshot 73

10.5.3. Product Portfolio 74

10.5.4. Recent Developments 74

10.6. Quick Biology 75

10.6.1. Company Overview 75

10.6.2. Quick Biology: Company Snapshot 75

10.6.3. Product Portfolio 75

10.6.4. Recent Developments 75

10.7. New York Blood Center 76

10.7.1. Company Overview 76

10.7.2. New York Blood Center: Company Snapshot 76

10.7.3. Product Portfolio 76

10.7.4. Recent Developments 76

10.8. The Sequencing Center 77

10.8.1. Company Overview 77

10.8.2. The Sequencing Center: Company Snapshot 77

10.8.3. Product Portfolio 78

10.8.4. Recent Developments 78

10.9. Bloodcenter Of Wisconsin 79

10.9.1. Company Overview 79

10.9.2. Bloodcenter Of Wisconsin: Company Snapshot 79

10.9.3. Product Portfolio 79

10.9.4. Recent Developments 79

10.10. Laboratory Corporation Of America Holdings 80

10.10.1. Company Overview 80

10.10.2. Laboratory Corporation Of America Holdings: Revenue Analysis 80

10.10.3. Product Portfolio 81

10.10.4. Recent Developments 81

10.11. Thermo Fisher Scientific Inc. 82

10.11.1. Company Overview 82

10.11.2. Thermo Fisher Scientific Inc. :Revenue Analysis 82

10.11.3. Product Portfolio 83

10.11.4. Recent Developments 83

11. Related Reports 84


List Of Figure

Figures List

Figure 1 North America Hla Typing Transplant Diagnostics Services Market: Segmentation 18

Figure 2 North America Hla Typing Transplant Diagnostics Services Market: Data Triangulation 21

Figure 3 North America Hla Typing Transplant Diagnostics Services Market: Research Snapshot 22

Figure 4 North America Hla Typing Transplant Diagnostics Services Market: Bottom Up Approach 23

Figure 5 North America Hla Typing Transplant Diagnostics Services Market: Top Down Approach 23

Figure 6 North America Hla Typing Transplant Diagnostics Services Market: Interview Demographics 24

Figure 7 Drivers, Restraints, Opportunities, And Challenges Of North America Hla Typing Transplant Diagnostics Services Market 27

Figure 8 Healthcare Expenditure In Few Emerging Countries (2000, 2010 & 2014) 31

Figure 9 Number Of Donors, Recipeints And Waiting Patients In U.S. From 2010 To 2015 32

Figure 10 North America Hla Typing Transplant Diagnostics Services Market: Segmentation 35

Figure 11 Technological Advancements In Hla Typing, Increasing Number Of Solid Organ And Stem Cell Transplantation Procedures Are Expected To Drive The Market For North America Hla Typing Transplant Diagnostics Services In The Forecast Period 2018 To 2025 36

Figure 12 Polymerase Chain Reaction (Pcr) Segment Is Expected To Account For The Largest Share Of The North America Hla Typing Transplant Diagnostics Services Market In 2018 & 2025 37

Figure 13 Asia Pacific Is The Highest Growing And Most Profitable Revenue Pockets For Hla Typing Transplant Diagnostics Services Manufacturers In The Forecast Period From 2018 To 2025 38

Figure 14 North America Hla Typing Transplant Diagnostics Services Market: By Technology, 2017 40

Figure 15 North America Hla Typing Transplant Diagnostics Services Market: By End-User, 2017 47

Figure 16 North America Hla Typing Transplant Diagnostics Services Market: Snapshot (2017) 53

Figure 17 North America Hla Typing Transplant Diagnostics Services Market: By Country (2017) 55

Figure 18 North America Hla Typing Transplant Diagnostics Services Market : By Country (2018 & 2025) 56

Figure 19 North America Hla Typing Transplant Diagnostics Services Market, By Country (2017 & 2025) 57

Figure 20 North America Hla Typing Transplant Diagnostics Services Market, By Product (2018-2025) 58

Figure 21 North America Hla Typing Transplant Diagnostics Services Market: Company Share 2017 (%) 67


List Of Table

Table List

Table 1 Cost Of Different Ngs Devices 30

Table 2 North America Hla Typing Transplant Diagnostics Services Market, By Technology, 2016- 2025 (Usd Million) 41

Table 3 North America Hla Typing Transplant Diagnostics Services Market, Next-Generation Sequencing (Ngs), By Region, 2016-2025 (Usd Million) 42

Table 4 North America Hla Typing Transplant Diagnostics Services Market, Polymerase Chain Reaction (Pcr), By Technique, 2016-2025 (Usd Million) 43

Table 5 North America Hla Typing Transplant Diagnostics Services Market, Polymerase Chain Reaction (Pcr), By Region, 2016-2025 (Usd Million) 44

Table 6 North America Hla Typing Transplant Diagnostics Services Market, By End-User, 2016-2025 (Usd Million) 48

Table 7 North America Hla Typing Transplant Diagnostics Services Market, Specialty Clinics, By Region, 2016-2025 (Usd Million) 49

Table 8 North America Hla Typing Transplant Diagnostics Services Market, Hospitals, By Region, 2016-2025 (Usd Million) 50

Table 9 North America Hla Typing Transplant Diagnostics Services Market, Transplant Centers, By Region, 2016-2025 (Usd Million) 51

Table 10 North America Hla Typing Transplant Diagnostics Services Market, Academic Institutes, By Region, 2016-2025 (Usd Million) 52

Table 11 North America Hla Typing Transplant Diagnostics Services Market, By Country, 2016-2025 (Usd Million) 59

Table 12 North America Hla Typing Transplant Diagnostics Services Market By Technology, 2016-2025 (Usd Million) 59

Table 13 North America Polymerase Chain Reaction (Pcr) Market , By Technique, 2016-2025 (Usd Million) 60

Table 14 North America Hla Typing Transplant Diagnostics Services Market By End-User, 2016-2025 (Usd Million) 60

Table 15 U.S. Hla Typing Transplant Diagnostics Services Market , By Technology, 2016-2025 (Usd Million) 61

Table 16 U.S. Polymerase Chain Reaction (Pcr) Market , By Technique, 2016-2025 (Usd Million) 61

Table 17 U.S. Hla Typing Transplant Diagnostics Services Market , By End-User, 2016-2025 (Usd Million) 62

Table 18 Canada Hla Typing Transplant Diagnostics Services Market , By Technology, 2016-2025 (Usd Million) 63

Table 19 Canada Polymerase Chain Reaction (Pcr) Market , By Technique, 2016-2025 (Usd Million) 63

Table 20 Canada Hla Typing Transplant Diagnostics Services Market , By End-User, 2016-2025 (Usd Million) 64

Table 21 Mexico Hla Typing Transplant Diagnostics Services Market , By Technology, 2016-2025 (Usd Million) 65

Table 22 Mexico Polymerase Chain Reaction (Pcr) Market , By Technique, 2016-2025 (Usd Million) 65

Table 23 Mexico Hla Typing Transplant Diagnostics Services Market , By End-User, 2016-2025 (Usd Million) 66

Licence Rights

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

Thermo Fisher Scientific Inc.

Proimmune ltd.

Laboratory Corporation Of America Holdings

Creative Biolabs and

Histogenetics LLC

THE UCLA immunogenetics center.

Admera Health

Quick Biology

NEW YORK blood center

The Sequencing Center

Bloodcenter of Wisconsin

Thermo Fisher Scientific Inc.

North America HLA typing transplant diagnostics services is expected to register a healthy CAGR in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

The major factors contributing to the growth of the market includes factors such as technological advancements in HLA typing, increasing number of solid organ and stem cell transplantation procedures and increased research grants, funds, and public-private investments.

The key market players for North America HLA typing transplant diagnostics services are listed below:

Thermo Fisher Scientific Inc.

Proimmune ltd.

Laboratory Corporation Of America Holdings

Creative Biolabs and

Histogenetics LLC

THE UCLA immunogenetics center.

Admera Health

Quick Biology

NEW YORK blood center

The Sequencing Center

Bloodcenter of Wisconsin

Thermo Fisher Scientific Inc.

The market is further segmented into:

Technology

Technique

End-Users

The North America HLA typing transplant diagnostics services market is segmented on the basis of technology into polymerase chain reaction (PCR) and next-generation sequencing (NGS). In 2018, Polymerase Chain Reaction (PCR) is expected to dominate the hospital LIMS market with 52.0% market share growing at a CAGR of 8.6% in the forecast period 2018 to 2025. However, next-generation sequencing (NGS) segment is expected to grow at the highest CAGR in the forecast period.

The North America HLA typing transplant diagnostics services market is segmented on the basis of technique into PCR-SSP (Sequence-Specific Primer), PCR SSOP (Sequence-Specific Oligonucleotide) and PCR-SBT (Sequencing Based Typing). In 2018, PCR-SSP (Sequence-Specific Primer) is expected to dominate the market with highest market share and is growing at a healthy CAGR in the forecast period 2018 to 2025. However, PCR-SBT (Sequencing Based Typing) market segment is expected to grow at the highest CAGR in the forecast period.

The North America HLA typing transplant diagnostics services market is segmented on the basis of end-users into hospitals, transplant centers, specialty clinics and academic institutes. In 2018, on-premise hospital LIMS is expected to dominate the hospital LIMS market in the forecast period 2018 to 2025. However, hospitals market segment is expected to grow at the highest CAGR and is expected to reach USD 185.24 million in 2025.

Based on geography, the market is segmented into 3 geographical regions:

U.S.

Canada

Mexico

Covered in this report

The report covers the present scenario and the growth prospects of the North America HLA typing transplant diagnostics services for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.

READ MORE

Scope

Table Of Contents

1. Introduction 14

1.1. Objectives Of The Study 14

1.2. Market Definition 14

1.3. Overview Of North America Hla Typing Transplant Diagnostics Services Market 14

1.4. Currency And Pricing 15

1.5. Limitation 15

1.6. Markets Covered 16

2. Market Segmentation 18

2.1. Markets Covered 18

2.2. Geographic Scope 19

2.3. Years Considered For The Study 20

2.4. Currency And Pricing 20

2.5. Research Methodology 21

2.6. Primary Interviews With Key Opinion Leaders 24

2.7. Secondary Sources 25

2.8. Assumptions 25

3. Market Overview 26

3.1. Drivers 28

3.1.1. Technological Advancements In Hla Typing 28

3.1.2. Increasing Number Of Solid Organ And Stem Cell Transplantation Procedures 29

3.1.3. Increased Research Grants, Funds, And Public-Private Investments 29

3.2. Restraints 30

3.2.1. Weak Reimbursements For Organ Donation And Transplantation Procedures 30

3.2.2. Expensive Ngs And Pcr-Based Devices 30

3.3. Opportunities 31

3.3.1. Rising Healthcare Infrastructure In Emerging Nations 31

3.4. Challenges 32

3.4.1. Significant Gap Between Number Of Organs Donated And Organs Required Annually 32

3.4.2. Lack Of Trained Staff 33

4. Executive Summary 34

5. Premium Insights 36

6. North America Hla Typing Transplant Diagnostics Services Market, By Technology 39

6.1. Overview 40

6.2. Next-Generation Sequencing (Ngs) 42

6.3. Polymerase Chain Reaction (Pcr) 43

6.3.1. Pcr Ssop (Sequence-Specific Oligonucleotide) 44

6.3.2. Pcr Ssp (Sequence-Specific Primer) 44

6.3.3. Pcr-Sbt (Sequencing Based Typing) 45

7. North America Hla Typing Transplant Diagnostics Services Market, By End-User 46

7.1. Overview 47

7.2. Specialty Clinics 49

7.3. Hospitals 50

7.4. Transplant Centers 51

7.5. Academic Institutes 52

8. North America Hla Typing Transplant Diagnostics Services Market, By Geography 53

8.1. North America 53

8.1.1. U.S. 61

8.1.2. Canada 63

8.1.3. Mexico 65

9. North America Hla Typing Transplant Diagnostics Services Market, Company Landscape 67

9.1. Company Share Analysis: North America 67

10. Company Profiles 68

10.1. Proimmune Ltd. 68

10.1.1. Company Overview 68

10.1.2. Proimmune Ltd.: Company Snapshot 68

10.1.3. Product Portfolio 69

10.1.4. Recent Developments 69

10.2. Creative Biolabs 70

10.2.1. Company Overview 70

10.2.2. Creative Biolabs: Company Snapshot 70

10.2.3. Product Portfolio 70

10.2.4. Recent Developments 70

10.3. Histogenetics Llc 71

10.3.1. Company Overview 71

10.3.2. Histogenetics Llc: Company Snapshot 71

10.3.3. Product Portfolio 71

10.3.4. Recent Developments 71

10.4. The Ucla Immunogenetics Center 72

10.4.1. Company Overview 72

10.4.2. The Ucla Immunogenetics Center: Company Snapshot 72

10.4.3. Product Portfolio 72

10.4.4. Recent Developments 72

10.5. Admera Health 73

10.5.1. Company Overview 73

10.5.2. Admera Health: Company Snapshot 73

10.5.3. Product Portfolio 74

10.5.4. Recent Developments 74

10.6. Quick Biology 75

10.6.1. Company Overview 75

10.6.2. Quick Biology: Company Snapshot 75

10.6.3. Product Portfolio 75

10.6.4. Recent Developments 75

10.7. New York Blood Center 76

10.7.1. Company Overview 76

10.7.2. New York Blood Center: Company Snapshot 76

10.7.3. Product Portfolio 76

10.7.4. Recent Developments 76

10.8. The Sequencing Center 77

10.8.1. Company Overview 77

10.8.2. The Sequencing Center: Company Snapshot 77

10.8.3. Product Portfolio 78

10.8.4. Recent Developments 78

10.9. Bloodcenter Of Wisconsin 79

10.9.1. Company Overview 79

10.9.2. Bloodcenter Of Wisconsin: Company Snapshot 79

10.9.3. Product Portfolio 79

10.9.4. Recent Developments 79

10.10. Laboratory Corporation Of America Holdings 80

10.10.1. Company Overview 80

10.10.2. Laboratory Corporation Of America Holdings: Revenue Analysis 80

10.10.3. Product Portfolio 81

10.10.4. Recent Developments 81

10.11. Thermo Fisher Scientific Inc. 82

10.11.1. Company Overview 82

10.11.2. Thermo Fisher Scientific Inc. :Revenue Analysis 82

10.11.3. Product Portfolio 83

10.11.4. Recent Developments 83

11. Related Reports 84


List Of Figure

Figures List

Figure 1 North America Hla Typing Transplant Diagnostics Services Market: Segmentation 18

Figure 2 North America Hla Typing Transplant Diagnostics Services Market: Data Triangulation 21

Figure 3 North America Hla Typing Transplant Diagnostics Services Market: Research Snapshot 22

Figure 4 North America Hla Typing Transplant Diagnostics Services Market: Bottom Up Approach 23

Figure 5 North America Hla Typing Transplant Diagnostics Services Market: Top Down Approach 23

Figure 6 North America Hla Typing Transplant Diagnostics Services Market: Interview Demographics 24

Figure 7 Drivers, Restraints, Opportunities, And Challenges Of North America Hla Typing Transplant Diagnostics Services Market 27

Figure 8 Healthcare Expenditure In Few Emerging Countries (2000, 2010 & 2014) 31

Figure 9 Number Of Donors, Recipeints And Waiting Patients In U.S. From 2010 To 2015 32

Figure 10 North America Hla Typing Transplant Diagnostics Services Market: Segmentation 35

Figure 11 Technological Advancements In Hla Typing, Increasing Number Of Solid Organ And Stem Cell Transplantation Procedures Are Expected To Drive The Market For North America Hla Typing Transplant Diagnostics Services In The Forecast Period 2018 To 2025 36

Figure 12 Polymerase Chain Reaction (Pcr) Segment Is Expected To Account For The Largest Share Of The North America Hla Typing Transplant Diagnostics Services Market In 2018 & 2025 37

Figure 13 Asia Pacific Is The Highest Growing And Most Profitable Revenue Pockets For Hla Typing Transplant Diagnostics Services Manufacturers In The Forecast Period From 2018 To 2025 38

Figure 14 North America Hla Typing Transplant Diagnostics Services Market: By Technology, 2017 40

Figure 15 North America Hla Typing Transplant Diagnostics Services Market: By End-User, 2017 47

Figure 16 North America Hla Typing Transplant Diagnostics Services Market: Snapshot (2017) 53

Figure 17 North America Hla Typing Transplant Diagnostics Services Market: By Country (2017) 55

Figure 18 North America Hla Typing Transplant Diagnostics Services Market : By Country (2018 & 2025) 56

Figure 19 North America Hla Typing Transplant Diagnostics Services Market, By Country (2017 & 2025) 57

Figure 20 North America Hla Typing Transplant Diagnostics Services Market, By Product (2018-2025) 58

Figure 21 North America Hla Typing Transplant Diagnostics Services Market: Company Share 2017 (%) 67


List Of Table

Table List

Table 1 Cost Of Different Ngs Devices 30

Table 2 North America Hla Typing Transplant Diagnostics Services Market, By Technology, 2016- 2025 (Usd Million) 41

Table 3 North America Hla Typing Transplant Diagnostics Services Market, Next-Generation Sequencing (Ngs), By Region, 2016-2025 (Usd Million) 42

Table 4 North America Hla Typing Transplant Diagnostics Services Market, Polymerase Chain Reaction (Pcr), By Technique, 2016-2025 (Usd Million) 43

Table 5 North America Hla Typing Transplant Diagnostics Services Market, Polymerase Chain Reaction (Pcr), By Region, 2016-2025 (Usd Million) 44

Table 6 North America Hla Typing Transplant Diagnostics Services Market, By End-User, 2016-2025 (Usd Million) 48

Table 7 North America Hla Typing Transplant Diagnostics Services Market, Specialty Clinics, By Region, 2016-2025 (Usd Million) 49

Table 8 North America Hla Typing Transplant Diagnostics Services Market, Hospitals, By Region, 2016-2025 (Usd Million) 50

Table 9 North America Hla Typing Transplant Diagnostics Services Market, Transplant Centers, By Region, 2016-2025 (Usd Million) 51

Table 10 North America Hla Typing Transplant Diagnostics Services Market, Academic Institutes, By Region, 2016-2025 (Usd Million) 52

Table 11 North America Hla Typing Transplant Diagnostics Services Market, By Country, 2016-2025 (Usd Million) 59

Table 12 North America Hla Typing Transplant Diagnostics Services Market By Technology, 2016-2025 (Usd Million) 59

Table 13 North America Polymerase Chain Reaction (Pcr) Market , By Technique, 2016-2025 (Usd Million) 60

Table 14 North America Hla Typing Transplant Diagnostics Services Market By End-User, 2016-2025 (Usd Million) 60

Table 15 U.S. Hla Typing Transplant Diagnostics Services Market , By Technology, 2016-2025 (Usd Million) 61

Table 16 U.S. Polymerase Chain Reaction (Pcr) Market , By Technique, 2016-2025 (Usd Million) 61

Table 17 U.S. Hla Typing Transplant Diagnostics Services Market , By End-User, 2016-2025 (Usd Million) 62

Table 18 Canada Hla Typing Transplant Diagnostics Services Market , By Technology, 2016-2025 (Usd Million) 63

Table 19 Canada Polymerase Chain Reaction (Pcr) Market , By Technique, 2016-2025 (Usd Million) 63

Table 20 Canada Hla Typing Transplant Diagnostics Services Market , By End-User, 2016-2025 (Usd Million) 64

Table 21 Mexico Hla Typing Transplant Diagnostics Services Market , By Technology, 2016-2025 (Usd Million) 65

Table 22 Mexico Polymerase Chain Reaction (Pcr) Market , By Technique, 2016-2025 (Usd Million) 65

Table 23 Mexico Hla Typing Transplant Diagnostics Services Market , By End-User, 2016-2025 (Usd Million) 66

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Companies

Thermo Fisher Scientific Inc.

Proimmune ltd.

Laboratory Corporation Of America Holdings

Creative Biolabs and

Histogenetics LLC

THE UCLA immunogenetics center.

Admera Health

Quick Biology

NEW YORK blood center

The Sequencing Center

Bloodcenter of Wisconsin

Thermo Fisher Scientific Inc.